Multiplicom said this week that it has appointed Ian Gilham as chairman of the board.

Gilham was first COO, then CEO of in vitro diagnostics company Axis-Shield until it was acquired by Alere in November 2011. Prior to this, he was vice president of pharmacogenetics at GlaxoSmithKline. He has also held general management, marketing, business development, and R&D positions at Abbott Laboratories, Celltech, and Amersham.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.